We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01479972
First Posted: November 28, 2011
Last Update Posted: October 29, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Children's Infectious Diseases Clinical Research Unit (KID-CRU), South Africa
Triclinium Johannesburg, South Africa
University of Stellenbosch
HJ-CTC George, South Africa
Information provided by (Responsible Party):
Vakzine Projekt Management GmbH
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):